Advanced Search
Share
Current Issue
Journal Information
Back to article

Statistics

Follow this link to access the full text of the article

114
HEMOFÍLICO A GRAVE COM INIBIDOR DO FATOR VIII: ADMINISTRAÇÃO PROMISSORA DO EMICIZUMABE
H.C. Fonsecaa, H.H.F. Ferreiraa, A.C.C. Souzaa, M.C. Almeidaa, R.B.C. Fagundesa, C.C. Villarimb
a Universidade Potiguar (UnP), Natal, RN, Brasil
b Liga Norte Riograndense Contra o Câncer, Natal, RN, Brasil
Read
1964
Times
was read the article
1066
Total PDF
898
Total HTML
Share statistics
Article information
ISSN: 25311379
Original language: English
DOI:10.1016/j.htct.2020.10.115
The statistics are updated each day
Year/Month Html Pdf Total
2024 April 13 7 20
2024 March 33 26 59
2024 February 20 31 51
2024 January 20 13 33
2023 December 17 17 34
2023 November 34 27 61
2023 October 27 24 51
2023 September 32 37 69
2023 August 19 16 35
2023 July 17 21 38
2023 June 24 24 48
2023 May 30 20 50
2023 April 15 17 32
2023 March 24 19 43
2023 February 14 14 28
2023 January 15 26 41
2022 December 36 22 58
2022 November 25 23 48
2022 October 24 23 47
2022 September 19 24 43
2022 August 14 21 35
2022 July 19 32 51
2022 June 15 21 36
2022 May 14 23 37
2022 April 24 42 66
2022 March 9 17 26
2022 February 13 24 37
2022 January 12 19 31
2021 December 13 17 30
2021 November 23 28 51
2021 October 27 35 62
2021 September 29 29 58
2021 August 36 40 76
2021 July 21 36 57
2021 June 22 33 55
2021 May 22 37 59
2021 April 46 66 112
2021 March 27 41 68
2021 February 12 25 37
2021 January 13 19 32
2020 December 8 15 23
2020 November 21 15 36
Show all

Follow this link to access the full text of the article

Subscribe to our newsletter

Special content about COVID-19
Publish in
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
Idiomas
Hematology, Transfusion and Cell Therapy